These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8764346)

  • 1. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol.
    Martin CL; Palomo MA; Mcmahon EG
    J Pharmacol Exp Ther; 1996 Jul; 278(1):154-62. PubMed ID: 8764346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
    Kovács A; Magyar J; Bányász T; Nánási PP; Szénási G
    Br J Pharmacol; 2003 Aug; 139(8):1555-63. PubMed ID: 12922944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
    Cha Y; Wales A; Wolf P; Shahrokni S; Sawhney N; Feld GK
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of flecainide on atrial and ventricular refractoriness in rabbits in vitro and in vivo.
    Leung MW; Chan AP; So PP; Lowe GC; Guppy LJ; Walker MJ
    Proc West Pharmacol Soc; 2004; 47():42-5. PubMed ID: 15633609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.
    Wang Z; Fermini B; Nattel S
    J Pharmacol Exp Ther; 1993 Nov; 267(2):575-81. PubMed ID: 8246130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.
    Jurkiewicz NK; Sanguinetti MC
    Circ Res; 1993 Jan; 72(1):75-83. PubMed ID: 8417848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dofetilide and EGIS-7229, an antiarrhythmic agent possessing class III, IV, and IB activities, on myocardial refractoriness in hyperkalemia, hypokalemia, and during beta-adrenergic activation in the rabbit papillary muscle in vitro.
    Kovács A; Szénási G
    J Pharmacol Sci; 2006 Apr; 100(4):303-9. PubMed ID: 16603803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
    Wirth KJ; Knobloch K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):166-74. PubMed ID: 11218069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues.
    Wang ZG; Pelletier LC; Talajic M; Nattel S
    Circulation; 1990 Jul; 82(1):274-83. PubMed ID: 2114235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
    Schreieck J; Wang Y; Gjini V; Korth M; Zrenner B; Schömig A; Schmitt C
    J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1420-30. PubMed ID: 9436780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative frequency-dependent effects of three class Ic agents, Org 7797, flecainide, and propafenone, on ventricular action potential duration.
    Winslow E; Campbell JK
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):911-7. PubMed ID: 1725906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoproterenol specifically modulates reverse rate-dependent effects of d,l-sotalol, d-sotalol, and dofetilide.
    Marschang H; Brachmann J; Karolyi L; Kübler W; Schöls W
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):443-50. PubMed ID: 10710131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.
    Yamamoto W; Hashimoto N; Matsuura J; Machida T; Ogino Y; Kobayashi T; Yamanaka Y; Ishiwata N; Yamashita T; Tanimoto K; Miyoshi S; Fukuda K; Nakaya H; Ogawa S
    J Cardiovasc Pharmacol; 2014 May; 63(5):421-7. PubMed ID: 24805146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle.
    Yang T; Tande PM; Lathrop DA; Refsum H
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):429-36. PubMed ID: 1520650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
    Shinagawa K; Shiroshita-Takeshita A; Schram G; Nattel S
    Circulation; 2003 Mar; 107(10):1440-6. PubMed ID: 12642367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.
    Hashimoto N; Yamashita T; Tsuruzoe N
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):162-9. PubMed ID: 18287884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
    Wang Z; Pagé P; Nattel S
    Circ Res; 1992 Aug; 71(2):271-87. PubMed ID: 1628386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of rate-dependent shortening of action potential duration in guinea-pig ventricle; effects of IK1 and IKr blockade.
    Williams BA; Dickenson DR; Beatch GN
    Br J Pharmacol; 1999 Mar; 126(6):1426-36. PubMed ID: 10217537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.